Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00402545 · ClinicalTrials.gov registry record · Phase 1

C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

A Phase 1 study of Head and Neck Neoplasms, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
Phase 1
Development phase
29
Enrollment target
1
Study location

NCT00402545 is a Phase 1 study of Head and Neck Neoplasms that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 29 participants, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00402545, a Phase 1 study of Head and Neck Neoplasms, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
Phase 1
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to determine the safest and most effective dose of 5-FU that can be given with docetaxel (Taxotere), Cisplatin and cetuximab to patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck. We will also be studying the toxicity of this regimen of 4 drugs and the tumor response.

Conditions Studied

Head and Neck Neoplasms

Interventions

  • DRUG Docetaxel
  • DRUG Cisplatin
  • DRUG Cetuximab
  • DRUG 5-Fluorouracil

Study Locations (1)

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2007-01
Est. Completion 2009-07
Phase Phase 1

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00402545

The ClinicalTrials.gov registry entry for NCT00402545 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which Docetaxel is the first listed.

NCT00402545 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00402545 about?

NCT00402545 is a clinical study titled "C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck". The purpose of this research study is to determine the safest and most effective dose of 5-FU that can be given with docetaxel (Taxotere), Cisplatin and cetuximab to patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck. We will also be studying the toxicity of ...

What is the current status of trial NCT00402545?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2007-01. Estimated completion is 2009-07.

What conditions does trial NCT00402545 study?

This clinical trial studies the following conditions: Head and Neck Neoplasms.

What interventions are being tested in trial NCT00402545?

The interventions under investigation include: Docetaxel (DRUG), Cisplatin (DRUG), Cetuximab (DRUG), 5-Fluorouracil (DRUG).

Who is sponsoring clinical trial NCT00402545?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00402545 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Neoplasms

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.